Growth Metrics

Cardlytics (CDLX) Preferred Stock Liabilities (2016 - 2017)

Cardlytics (CDLX) has disclosed Preferred Stock Liabilities for 2 consecutive years, with $44.7 million as the latest value for Q4 2017.

  • For the quarter ending Q4 2017, Preferred Stock Liabilities rose 745.1% year-over-year to $44.7 million, compared with a TTM value of $44.7 million through Dec 2017, up 745.1%, and an annual FY2017 reading of $44.7 million, up 745.1% over the prior year.
  • Preferred Stock Liabilities was $44.7 million for Q4 2017 at Cardlytics, up from $5.3 million in the prior quarter.
  • Across five years, Preferred Stock Liabilities topped out at $44.7 million in Q4 2017 and bottomed at $5.3 million in Q4 2016.